1253522-03-0 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
2,3-Dichloro-6-(trifluoroMethoxy)quinoxaline is used as a chemical intermediate in the synthesis of pharmaceuticals and agrochemicals. Its unique structure allows for the development of new compounds with potential therapeutic and pesticidal properties.
Used in Material Science:
This quinoxaline derivative is used as a building block in the development of new materials with various industrial applications. Its structural features enable the creation of innovative materials with improved properties.
Used in Antimicrobial and Antifungal Applications:
2,3-Dichloro-6-(trifluoroMethoxy)quinoxaline has demonstrated antimicrobial and antifungal properties, making it a potential candidate for the development of new antimicrobial agents. Its ability to inhibit the growth of harmful microorganisms can contribute to the development of effective treatments and preventive measures against infections.
However, it is important to handle 2,3-Dichloro-6-(trifluoroMethoxy)quinoxaline with caution due to its potential health hazards and environmental impacts. Proper safety measures should be taken during its synthesis, use, and disposal to minimize any adverse effects.
Check Digit Verification of cas no
The CAS Registry Mumber 1253522-03-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,3,5,2 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1253522-03:
(9*1)+(8*2)+(7*5)+(6*3)+(5*5)+(4*2)+(3*2)+(2*0)+(1*3)=120
120 % 10 = 0
So 1253522-03-0 is a valid CAS Registry Number.
1253522-03-0Relevant articles and documents
Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient
-
Paragraph 0976-0979; 1282-1284, (2020/02/20)
Provided are a novel [1,2,4]triazolo[4,3-a]quinoxaline derivative, a method for preparing the same, and a pharmaceutical composition for preventing or treating bromodomain extra-terminal (BET) protein-related diseases including cancer and autoimmune disea
